Outliers of Treatment Frequency in Retinal Vein Occlusion: 24-Month Comparative Analysis of Fight Retinal Blindness! Practitioners Clinical & Experimental Ophthalmology , (epub) December 2024 Pubmed
Impact of cataract surgery on patients receiving intravitreal therapy for retinal vein occlusion Clinical & Experimental Ophthalmology , (epub) December 2024 Pubmed
The Fight Inherited Retinal Blindness! Project: A new treatment outcome and natural history registry for inherited retinal disease Retina February 2025 Pubmed
Treat-and-Extend Versus Pro re nata Regimens of Ranibizumab and Aflibercept in Neovascular Age-Related Macular Degeneration: A Comparative Study from Routine Clinical Practice Ophthalmology and Therapy September 2024 Pubmed
Fight Retinal Blindness SPAIN. Report 3: clinical outcomes of vascular endothelial growth factor inhibitors in low vision eyes with neovascular age-related macular degeneration. A national database study Eye , (epub) September 2024 Pubmed
One-year anti-VEGF therapy outcomes in diabetic macular edema based on treatment intensity: Data from the FRB! registry Ophthalmology. Retina , (epub) April 2024 Pubmed
European Unmet Needs in the Management of Neovascular Age-Related Macular Degeneration in Daily Practice: Data from the Fight Retinal Blindness! Registry Ophthalmology Retina June 2024 Pubmed
Development of a joint set of database parameters for the EU-ROP and Fight Childhood Blindness! ROP Registries British Journal of Ophthalmology June 2024 Pubmed
Macular Neovascularization type influence on anti-VEGF intravitreal therapy outcomes in Age-related Macular Degeneration Ophthalmology. Retina April 2024 Pubmed
Three-year outcomes of vascular endothelial growth factor inhibitors in naïve branch retinal vein occlusion: Fight Retinal Blindness! Ophthalmology. Retina October 2024 Pubmed
Initial response and 12-month outcomes after commencing dexamethasone or vascular endothelial growth factor inhibitors for retinal vein occlusion in the FRB registry Scientific Reports , (epub) March 2024 Pubmed
Twenty-four-month real-life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians Clinical and Experimental Ophthalmology November 2023 Pubmed